Bridget Wang

Bridget represents companies, investment banks and private equity funds in initial public offerings (IPOs) in the US and Hong Kong capital markets, pre-IPO equity investments, corporate governance of companies listed on the Hong Kong Stock Exchange (HKEX), and other corporate transactions.

Before joining Cooley, Bridget practiced in the Shanghai offices of a leading UK law firm and a People’s Republic of China law firm.

Bridget is a native Mandarin speaker and is fluent in English.

Representative matters:

Capital markets

• ImmuneOnco Biopharmaceuticals, a clinical-stage biotechnology company, in its HK$319 million IPO on the HKEX main board
• The placement of existing shares and the subscription of new shares on a top-up basis under general mandate of Jacobio Pharmaceuticals, with gross proceeds from the placement of HK$160.4 million
• STAR CM, a variety program intellectual property creator and operator, in its HK$390 million (US$50 million) IPO of 14,731,600 shares at a public offering price of HK$26.50 on the HKEX, subject to the overallotment option
• The joint sponsors – CICC, Citigroup and China Renaissance – in the H Share IPO of Huitongda Network, a leading ecommerce company backed by Alibaba, on the HKEX main board for HK$2.2 billion (approximately US$285 million)
• Keymed Biosciences in its US$400 million global offering and listing on the HKEX main board
• J.P. Morgan and Morgan Stanley as underwriters in Budweiser Brewing Company APAC’s US$5 billion global offering and listing on the HKEX main board*
• XD Inc. in its US$105 million global offering and listing on the HKEX main board*
• Morgan Stanley and Haitong International as underwriters in Hygeia Healthcare’s US$282 million global offering and listing on the HKEX main board*
• Morgan Stanley, BofA Securities and CLSA as underwriters in Hutchison MediPharma’s US$220 million global offering and listing on the HKEX main board*
• Goldman Sachs and CICC as underwriters in Angelalign Technology’s HK$2.9 billion (approximately US$376 million) global offering and listing on the HKEX main board*

Bond issuance

• Jiuquan Iron and Steel Group in its HK$500 million bond issuance in Hong Kong*
• Huangshan Tourism Group in its 230-million-euro bond issuance in Hong Kong*

HKEX compliance

• Jacobio Pharmaceuticals

* Representation handled before joining Cooley